Evoke Wealth’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.01M Buy
16,058
+4,034
+34% +$323K 0.02% 277
2025
Q4
$1.15M Buy
12,024
+2,011
+20% +$197K 0.02% 247
2025
Q3
$978K Buy
10,013
+3,543
+55% +$367K 0.02% 254
2025
Q2
$695K Buy
6,470
+2,632
+69% +$266K 0.02% 278
2025
Q1
$387K Buy
3,838
+297
+8% +$29.9K 0.01% 307
2024
Q4
$316K Buy
3,541
+738
+26% +$65K 0.01% 334
2024
Q3
$235K Buy
+2,803
New +$221K 0.01% 373
2022
Q4
Sell
-1,091
Closed -$42K 475
2022
Q3
$42K Buy
1,091
+86
+9% +$3.45K ﹤0.01% 541
2022
Q2
$37K Buy
1,005
+34
+4% +$1.38K ﹤0.01% 555
2022
Q1
$43K Buy
971
+115
+13% +$4.98K ﹤0.01% 544
2021
Q4
$36K Hold
856
﹤0.01% 575
2021
Q3
$37K Hold
856
﹤0.01% 548
2021
Q2
$37K Sell
856
-136
-14% -$5.72K ﹤0.01% 558
2021
Q1
$38K Buy
992
+132
+15% +$5K ﹤0.01% 484
2020
Q4
$31K Hold
860
﹤0.01% 435
2020
Q3
$33K Hold
860
﹤0.01% 410
2020
Q2
$30K Sell
860
-5
-0.6% -$180 ﹤0.01% 411
2020
Q1
$28.2K Sell
865
-276
-24% -$10.8K ﹤0.01% 392
2019
Q4
$51.6K Sell
1,141
-13
-1% -$544 0.01% 402
2019
Q3
$47K Buy
+1,154
New +$48.9K 0.01% 478

Other funds holding BSX

Evoke Wealth's BSX Position: Q1 2026 in Review

Evoke Wealth increased its Boston Scientific (BSX) stake by 34% in Q1 2026, buying an estimated $323K and bringing the position to 16,058 shares worth $1.01M. The position accounts for 0.02% of the portfolio, ranked #277.

Evoke Wealth first reported a position in BSX in Q3 2019 and has held it in 20 quarters since. The position peaked at $1.15M in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Evoke Wealth held 16,058 shares of Boston Scientific worth $1.01M as of Q1 2026.
  • Evoke Wealth bought 4,034 Boston Scientific shares in Q1 2026, an estimated $323K.
  • Boston Scientific made up 0.02% of Evoke Wealth's portfolio in Q1 2026, its #277 holding.
  • Evoke Wealth first reported a position in Boston Scientific in Q3 2019 and has held it in 20 quarters since.
  • Evoke Wealth's Boston Scientific position peaked at $1.15M in Q4 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Evoke Wealth's 13F filing for Q1 2026, filed 15 May 2026.